Stock Scorer

Volitionrx Ltd (VNRX) · Peers

Volitionrx against the 15 other companies here in its SEC industry, In Vitro & In Vivo Diagnostic Substances. Each figure is the one on the company's own page; the median is the peers', and the rank is among all 16, highest first.

Measure by measure

MeasureVNRXPeer medianRank
Market value $2.46M median $380.11M 16 of 16
P/S 1.0× median 4.9× 14 of 16
FCF yield -796.7% median -7.8% 15 of 15
Operating margin -790.2% median -12.2% 12 of 12
Net margin -1043.1% median -14.0% 12 of 12
Revenue growth (4y, yearly) 109.3% median 8.7% 1 of 15
Current ratio 0.3× median 3.5× 15 of 15
Stock pay / revenue 70.8% median 4.3% 4 of 15
Share count change 23.5% median 6.2% 4 of 15

Green where Volitionrx is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.

The peers, largest first

CompanyMarket valueP/EROICScore
VNRXVolitionrx Ltd $2.46M P/E – – 4.1
IDXXIDEXX Laboratories Inc $44.15B P/E 38.7× 57.2% 6.8
LNTHLantheus Holdings, Inc. $6.53B P/E 23.7× 18.5% 7.7
NEOGNeogen Corp $2.59B P/E – -0.6% 4.4
CLDXCelldex Therapeutics, Inc. $2.24B P/E – – 2.7
NTLAIntellia Therapeutics, Inc. $1.63B P/E – -115.4% 3.8
QDELQuidelOrtho Corp $913.77M P/E – -13.8% 3.0
MYGNMyriad Genetics Inc $389.29M P/E – -25.2% 5.3
TKNOAlpha Teknova, Inc. $380.11M P/E – -21.4% 4.3
NNNNAnbio Biotechnology $140.54M P/E 21.9× 25.0% 6.7
IMDXInsight Molecular Diagnostics Inc. $98.50M P/E – – 3.4
ICCCImmucell Corp $97.63M P/E 25.9× 9.8% 7.2
AWHLAspira Women's Health Inc. $10.73M P/E – – 4.5
BMRABiomerica Inc $8.49M P/E – -213.5% 3.0
CDIOCardio Diagnostics Holdings, Inc. $5.00M P/E – -68.7% 3.7
QCLSQ/C Technologies, Inc. $4.22M P/E – – 8.0

The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.